Pruritus Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Pruritus Epidemiology Forecast Report Coverage

Expert Market Research's “Pruritus Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of pruritus. It projects the future incidence and prevalence rates of pruritus cases across various populations. The study covers age, gender, and type as major determinants of the pruritus population. The report highlights patterns in the prevalence of pruritus over time and projects future trends based on multiple variables.

Pruritus Understanding: Disease Overview

Pruritus, commonly known as itching, is a distressing symptom arising from dermatological, systemic, neurological, or psychogenic causes. It may be localized or generalized and often signals underlying conditions such as eczema, chronic kidney disease, or cholestasis. Chronic pruritus severely impacts quality of life, leading to sleep disturbances and psychological distress. The pathophysiology involves complex interactions between skin nerves, immune responses, and central nervous system pathways influencing itch perception.

Pruritus Epidemiology Perspective

The pruritus epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the pruritus epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for pruritus and its trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• A 2024 international study involving 50,552 individuals across 20 countries reported a one-week prevalence of pruritus at 39.8%, with the highest rates observed in adults aged 65 and older (43.3%).
• Older adults (aged over 65) demonstrated the highest burden of pruritus, emphasizing the association between aging and increased skin sensitivity or comorbidities.
• The same study found women were more frequently affected (40.7%) compared to men (38.9%), highlighting a subtle gender disparity.
• This difference is attributed to hormonal influences, higher rates of autoimmune disorders, and increased skin sensitivity among women.

Read more about this report - Request a Free Sample

Country-wise Pruritus Epidemiology Segment

The pruritus epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country-wise, the burden of pruritus shows notable variation. In the United States, chronic pruritus affects between 8-25.5% of the population, with around 7% newly affected each year. It ranks among the top 50 most common health conditions and accounts for over 7 million outpatient visits annually. In India, a 2023 study on hemodialysis patients found that 55.8% experienced uremic pruritus, predominantly mild, yet significantly impacting sleep and quality of life, independent of dialysis-related factors. This highlights regional differences in underlying causes.

Pruritus: Treatment Overview

Treatment of pruritus targets the underlying cause, where possible. Topical therapies, including emollients, corticosteroids, and antihistamines, relieve skin-related itch. Systemic agents like gabapentinoids, antidepressants, or immunosuppressants are considered for refractory cases. In systemic pruritus, managing the primary condition is key. Phototherapy and targeted biologics may help in chronic dermatologic cases. A multidisciplinary approach addressing both physical and psychological impacts ensures comprehensive symptom relief and improved patient outcomes.

Key Questions Answered

• What are the key findings of pruritus epidemiology in the 8 major markets?
• What will be the total number of patients with pruritus across the 8 major markets during the forecast period?
• What was the country-wise pruritus epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of pruritus patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of pruritus during the forecast period of 2026-2035?
• What are the currently available treatments for pruritus?
• What are the disease risks, signs, symptoms, and unmet needs of pruritus?

Scope of the Pruritus Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of pruritus based on several factors.
• Pruritus Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The pruritus report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Pruritus Drugs Market Report

Pruritus Drug Pipeline Analysis Report